network member

Fox Chase Cancer Center

333 Cottman Avenue, Philadelphia, PA 19111

About Network Member

Website: Fox Chase Cancer Center

https://www.foxchase.org

Michael Oldfield

215-214-3769

Currently Enrolling

HCRN-GU16-243

PhAse I/II StuDy of Modern ImmunotherApy in BCG-RelaPsing UroThelial Carcinoma of the BLADDER – (ADAPT-BLADDER) HCRN GU16-243

Noah M. Hahn

Cancer areas:Bladder Urothelial Carcinoma

Columbia University Irving Medical Center

Fox Chase Cancer Center

Fred & Pamela Buffett Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

University of Iowa Holden Comprehensive Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-GU16-260

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Michael B. Atkins

Cancer areas:Kidney

Beth Israel Deaconess Medical Center

Cleveland Clinic Cancer Center

Columbia University Irving Medical Center

Fox Chase Cancer Center

Georgetown Lombardi Comprehensive Cancer Center

Penn Medicine Abramson Cancer Center

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

University of Illinois Cancer Center

UT Southwestern Harold C. Simmons Comprehensive Cancer Center

Winship Cancer Institute of Emory University

Yale Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-MEL16-252

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252

Robert R. McWilliams

Cancer areas:Melanoma

Fox Chase Cancer Center

Masonic Cancer Center, University of Minnesota

Mayo Clinic

Nebraska Cancer Specialists

Providence Cancer Institute

University of Iowa Holden Comprehensive Cancer Center

See clinicaltrials.gov